BARBARA ADAMIAK: Open Payments
NPI 1013261429 · SUN CITY CENTER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,456 in 196 payments from 47 companies in 2025. Trend: 2023 $334 · 2024 $3,531 · 2025 $4,456
Food & beverage: $4,372Education: $84
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 21 | $427 |
| AstraZeneca Pharmaceuticals LP | 15 | $325 |
| Novartis Pharmaceuticals Corporation | 17 | $321 |
| Incyte Corporation | 9 | $288 |
| Astellas Pharma US Inc | 10 | $237 |
| E.R. Squibb & Sons, L.L.C. | 10 | $218 |
| Gilead Sciences, Inc. | 10 | $218 |
| Janssen Biotech, Inc. | 8 | $185 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $158 |
| Celgene Corporation | 5 | $154 |
Products named: Trodelvy, ENHERTU, OPDIVO, Vyloy, IBRANCE, PADCEV, IMFINZI, RYBREVANT.
Industry payments across FL — which companies pay providers there.
